What is the recommended treatment for Chlamydia (Chlamydia trachomatis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Chlamydia Treatment

For uncomplicated genital chlamydia in non-pregnant adults, treat with either azithromycin 1 g orally as a single dose or doxycycline 100 mg orally twice daily for 7 days—both achieve approximately 97-98% cure rates and are equally effective. 1, 2, 3

First-Line Treatment Selection

Choose between the two first-line options based on these specific factors:

Azithromycin 1 g single dose is preferred when:

  • Compliance with a 7-day regimen is questionable 1, 2
  • Follow-up is unpredictable or unlikely 2
  • Directly observed therapy is needed 1, 3
  • Treating young adults or populations with erratic health-care-seeking behavior 2

Doxycycline 100 mg twice daily for 7 days is preferred when:

  • Cost is a primary concern (significantly less expensive than azithromycin) 2
  • The patient can reliably complete a 7-day course 2
  • There is extensive clinical experience with this regimen 3

Critical Management Steps

Medication dispensing and observation:

  • Dispense medications on-site whenever possible 1, 2
  • Directly observe the first dose to maximize compliance 1, 2

Sexual abstinence requirements:

  • Patients must abstain from all sexual intercourse for 7 days after initiating treatment 1, 2
  • Continue abstinence until all sex partners have completed treatment 1, 2

Partner management (non-negotiable):

  • All sex partners from the preceding 60 days must be evaluated, tested, and empirically treated 1, 2
  • If last sexual contact was >60 days before diagnosis, still treat the most recent partner 1
  • Failing to treat partners leads to reinfection in up to 20% of cases 1

Treatment During Pregnancy

Azithromycin 1 g orally as a single dose is the preferred treatment during pregnancy. 1, 2

Alternative options if azithromycin cannot be used:

  • Amoxicillin 500 mg orally three times daily for 7 days 1, 2
  • Erythromycin base 500 mg orally four times daily for 7 days 1, 2

Absolute contraindications in pregnancy:

  • Doxycycline 1, 2
  • Ofloxacin 1, 2
  • Levofloxacin 1, 2

Alternative Treatment Regimens (Only When First-Line Cannot Be Used)

Use these only when azithromycin and doxycycline are contraindicated or not tolerated:

  • Levofloxacin 500 mg orally once daily for 7 days 1, 2
  • Ofloxacin 300 mg orally twice daily for 7 days 1, 2
  • Erythromycin base 500 mg orally four times daily for 7 days 1, 2
  • Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 1, 2

Important caveat: Erythromycin is less efficacious than azithromycin or doxycycline, and gastrointestinal side effects frequently lead to poor compliance. 1, 2, 3

Pediatric Dosing

For children ≥8 years weighing >45 kg:

  • Azithromycin 1 g orally as a single dose, OR 1, 2
  • Doxycycline 100 mg orally twice daily for 7 days 1, 2

For children <45 kg:

  • Erythromycin base or ethylsuccinate 50 mg/kg/day orally divided into four doses daily for 14 days 1, 2

For infants with chlamydial pneumonia (ages 1-3 months):

  • Erythromycin base or ethylsuccinate 50 mg/kg/day orally divided into four doses daily for 14 days 1
  • Treatment effectiveness is approximately 80%; a second course may be needed 1

Follow-Up and Retesting

Test-of-cure is NOT recommended for non-pregnant patients treated with recommended regimens. 1, 2

  • Treatment failure rates are extremely low: 0-3% in males, 0-8% in females 2
  • Testing before 3 weeks post-treatment is unreliable due to false-positive results from dead organisms 1

Test-of-cure IS mandatory in these situations:

  • All pregnant patients (test 3-4 weeks after treatment completion) 1, 2
  • Questionable therapeutic compliance 1, 2
  • Persistent symptoms 1, 2
  • Suspected reinfection 1, 2

Reinfection screening (distinct from test-of-cure):

  • All women with chlamydia should be retested approximately 3 months after treatment, regardless of whether partners were reportedly treated 1, 2
  • Reinfection rates can reach 39% in some adolescent populations 1, 2
  • Repeat infections carry elevated risk for pelvic inflammatory disease and other complications 1

Additional STI Testing

At the initial visit, patients diagnosed with chlamydia should be tested for:

  • Gonorrhea 1
  • Syphilis 1
  • HIV 1

Common pitfall: If gonorrhea is confirmed or prevalence is high in the patient population, always treat presumptively for both infections, as coinfection rates are substantial. 1

References

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.